Literature DB >> 10564169

Expression of type II Na-P(i) cotransporter in alveolar type II cells.

M Traebert1, O Hattenhauer, H Murer, B Kaissling, J Biber.   

Abstract

Type II Na-P(i) cotransporters (type IIa and type IIb) represent apically located Na-P(i) cotransporters in epithelia of proximal tubules (type IIa) and small intestine (type IIb). Here we provide evidence that the type IIb (but not the type IIa) Na-P(i) cotransporter is also expressed in the lung. With the use of immunohistochemistry, location of the type IIb protein was found exclusively in the apical membrane of type II cells of the alveolar epithelium. Such a location of the type IIb cotransporter suggests an involvement in the reuptake of phosphate necessary for the synthesis of surfactant. A possible regulation of the abundance of the type IIb cotransporter in the lung was studied after adaptation of mice to a low-P(i) diet. After a chronic adaptation to a low-P(i) diet, no changes in the type IIb protein and the type IIb transcript were observed. These results exclude dietary intake of phosphate as a regulatory factor of the type IIb Na-P(i) cotransporter in alveolar type II cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564169     DOI: 10.1152/ajplung.1999.277.5.L868

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  42 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 2.  Pulmonary alveolar microlithiasis: a case report and review of the literature.

Authors:  M Proesmans; M Boon; E Verbeken; U Ozcelik; N Kiper; W Van de Casseye; K De Boeck
Journal:  Eur J Pediatr       Date:  2012-02-04       Impact factor: 3.183

3.  Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.

Authors:  Beatrice W T Yin; Ramziya Kiyamova; Ramon Chua; Otavia L Caballero; Ivan Gout; Vitalina Gryshkova; Nimesh Bhaskaran; Serhiy Souchelnytskyi; Ulf Hellman; Valeriy Filonenko; Achim A Jungbluth; Kunle Odunsi; Kenneth O Lloyd; Lloyd J Old; Gerd Ritter
Journal:  Cancer Immun       Date:  2008-02-06

Review 4.  Knowns and unknowns of the alveolus.

Authors:  Erica L Herzog; Arnold R Brody; Thomas V Colby; Robert Mason; Mary C Williams
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

5.  Intestinal phosphate absorption: The paracellular pathway predominates?

Authors:  Matthew Saurette; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-14

6.  Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema.

Authors:  M Schläpfer; A C Leutert; S Voigtsberger; R A Lachmann; C Booy; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

7.  Amino acids involved in sodium interaction of murine type II Na(+)-P(i) cotransporters expressed in Xenopus oocytes.

Authors:  C de La Horra; N Hernando; I Forster; J Biber; H Murer
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

8.  Characterizing and evaluating the expression of the type IIb sodium-dependent phosphate cotransporter (slc34a2) gene and its potential influence on phosphorus utilization efficiency in yellow catfish (Pelteobagrus fulvidraco).

Authors:  Pei Chen; Qin Tang; Chunfang Wang
Journal:  Fish Physiol Biochem       Date:  2015-08-23       Impact factor: 2.794

9.  Gene expression changes during the development of acute lung injury: role of transforming growth factor beta.

Authors:  Scott C Wesselkamper; Lisa M Case; Lisa N Henning; Michael T Borchers; Jay W Tichelaar; John M Mason; Nadine Dragin; Mario Medvedovic; Maureen A Sartor; Craig R Tomlinson; George D Leikauf
Journal:  Am J Respir Crit Care Med       Date:  2005-08-11       Impact factor: 21.405

10.  Expression of the Na/P(i)-cotransporter type IIb in Sf9 cells: functional characterization and purification.

Authors:  T Radanovic; H Murer; J Biber
Journal:  J Membr Biol       Date:  2003-07-15       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.